Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
2025 global health care executive outlook
Kailera seeks to differentiate GLP-1/GIP agonist after partners Phase III China data Jiangsu Hengruis HRS9531 shows 17.7% placebo-adjusted weight loss at top dose Data from a Phase III study of HRS9531 in China support Jiangsu Hengruis bid for domestic approval to treat obesity, but fail to clearly differentiate the dual GLP-1/GIP agonist from established or emerging competitors
At the same time, Zepbound and NAION is a potentially permanently impairing optic nerve event that warrants explicit education and an immediate-action plan, as do other serious Zepbound eye issues
Perdita di peso : in virt del ruolo di trasportatore mitocondriale di acidi grassi a lunga catena, alla Carnitina sono state da sempre attribuite attivit lipolitiche, potenzialmente utili nella lotta all'obesit
It is commonly used as part of a wellness program focused on physical recovery and tissue health
